Biosite Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Files premarket approval application with FDA Dec. 8 for its Triage diagnostic for congestive heart failure. The blood test, which would be the first to aid in diagnosing CHF, measures B-type natriuretic peptide, a protein marker for congestive heart failure, to provide diagnostic information to the physician within 20 minutes